Which of the following is a common bronchodilator used in the management of asthma?

Albuterol is commonly used as a bronchodilator in the management of asthma due to its rapid onset of action and effectiveness in relieving bronchospasm. It belongs to a class of medications known as short-acting beta-agonists (SABAs), which stimulate beta-2 adrenergic receptors in the smooth muscle of the airways, leading to relaxation and opening of bronchial passages. This makes it particularly useful during asthma attacks or episodes of acute wheezing.

In contrast to albuterol, montelukast is a leukotriene receptor antagonist that works by inhibiting substances that cause inflammation and constriction in the airways. While it is beneficial in asthma management, it does not act as a bronchodilator in the same way that albuterol does.

Ipratropium bromide is an anticholinergic medication that may also be used as a bronchodilator, particularly in cases of exacerbations or as an add-on therapy, but it is typically more effective for conditions like COPD rather than as a primary treatment for acute asthma attacks.

Corticosteroids are primarily anti-inflammatory agents and are used for long-term management to reduce airway inflammation in asthma. They do not directly act as bronchodilators and would not be